Creative Planning Adial Pharmaceuticals, Inc. Transaction History

Creative Planning

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 21, 2023	BUY	$0.21 - $0.37 $2,100 - $3,700	10,000 New	10,000 $2,000
Q2 2021 Aug 04, 2021	SELL	$50.5 - $78.25 $505,000 - $782,500	-10,000 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$43.25 - $79.75 $432,500 - $797,500	10,000 New	10,000 $24,000

5.5K

Ticker ADIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,854,000
Market Cap $27.1M
Description
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focu...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.